Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Zhejiang Anglikang Pharmaceutical Co., Ltd.

Clinical trials sponsored by Zhejiang Anglikang Pharmaceutical Co., Ltd., explained in plain language.

Zhejiang Anglikang Pharmaceutical Co., Ltd. 002940 SZSE

A Chinese pharmaceutical company producing generic drugs and active pharmaceutical ingredients.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet recruiting 1 Not yet finished but already full! 1

New cancer drug ALK-N001 enters early human testing

Disease control Terminated

This early-phase trial tests a new drug called ALK-N001 in people with advanced solid tumors, including esophageal, lung, and stomach cancers. The main goals are to check safety, find the right dose, and see how the drug moves through the body. Only 16 participants were enrolled,…

Phase: PHASE1 • Sponsor: Zhejiang Anglikang Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 12:09 UTC